$72.770
+0.982 (+1.35%)收盘时
UTMD 资讯
UTMD 事件
Company Reports Q2 Revenue of $8.5M
Reports Q2 revenue $8.5M vs. $9.95M last year.
Q1 Revenue Reports $8.72M vs. $9.71M Last Year
Reports Q1 revenue $8.72M vs. $9.71M last year.
Company Reports Q4 Revenue of $9.04M
Reports Q4 revenue $9.04M vs. $9.16M last year.
Utah Medical Products Increases Quarterly Cash Dividend by 1.6% to $0.31 per Share
Utah Medical Products announces that its board of directors has appointed Kevin C. Timken, Esq to its board. In addition, the board approved a quarterly cash dividend of 31c per share of common stock payable on January 5 to shareholders of record at the close of business on December 16. This is a 1.6% increase over the prior regular quarterly cash dividend.
Utah Medical Products announces Q3 earnings per share of 82 cents, down from $1.03 a year ago.
Reports Q3 revenue $9.8M vs. $10M last year.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。






